Top Markets
#1 Black Phoenix Black Phoenix +21,406.19%
#2 Nesa Nesa +679.66%
#3 Cortex Cortex +92.45%
#4 Ontology Gas Ontology Gas +59.74%
#5 Kinesis Silver Kinesis Silver +53.75%
#6 Biconomy Biconomy +26.93%
#7 Magma Finance Magma Finance +24.36%
#8 QuantixAI QuantixAI +23.07%
#9 EXOD EXOD +22.78%
#10 SAFEcoin SAFEcoin +20.40%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rank in Stocks #18871
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Share Price
$2.51
Market Cap
$183.34M
Change (1 day)
0.90%
Change (1 year)
91.17%
Country
TW
Trade Steminent Biotherapeutics Inc. (7729)

Category

Healthcare
P/E ratio for Steminent Biotherapeutics Inc. (7729)
P/E ratio as of 2026 TTM: 0
According to Steminent Biotherapeutics Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Steminent Biotherapeutics Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.